BioCryst Pharmaceuticals
IPOBioCryst® | A Pioneer in Rare Disease Therapeutics
Public · Durham, United States · Founded 1986
- Headquarters
- Durham, North Carolina
- Employees
- 201–500
- Founded
- 1986
- Business Model
- B2B
- Website
- biocryst.com
- Type
- Public
About
Rare disease biopharmaceutical company pioneering oral treatments for hereditary angioedema and other rare conditions.
Summary
BioCryst Pharmaceuticals is a Biotech company based in Durham, United States, founded in 1986. Investors include Royalty Pharma, OMERS Capital Markets and Athyrium Capital Management.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...